XOMA Stock (NASDAQ:XOMA)


RevenueOwnershipFinancialsChart

Previous Close

$30.07

52W Range

$14.33 - $33.78

50D Avg

$28.95

200D Avg

$26.35

Market Cap

$355.84M

Avg Vol (3M)

$25.13K

Beta

0.90

Div Yield

$2.16 (1.55%)

XOMA Company Profile


XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

13

IPO Date

Jun 06, 1986

Website

XOMA Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Asia Pacific---
UNITED STATES---
United States---
Europe---

Fiscal year ends in Dec 23 | Currency in USD

XOMA Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income---
Net Income---
EBITDA---
Basic EPS---
Diluted EPS---

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q4 16Mar 17, 17 | 3:47 AM
Q4 15Mar 09, 16 | 8:30 PM
Q3 15Nov 05, 15 | 7:51 PM

Peer Comparison


TickerCompany
SIOXSio Gene Therapies Inc.
TALSTourmaline Bio, Inc.
DYNDyne Therapeutics, Inc.
RVMDRevolution Medicines, Inc. Warrant
DBTXDecibel Therapeutics, Inc.
ACHLAchilles Therapeutics plc
EWTXEdgewise Therapeutics, Inc.
STOKStoke Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
PASGPassage Bio, Inc.
CCCCC4 Therapeutics, Inc.
CRNXCrinetics Pharmaceuticals, Inc.
DSGNDesign Therapeutics, Inc.
RZLTRezolute, Inc.
HOWLWerewolf Therapeutics, Inc.
VINCVincerx Pharma, Inc.
THRDThird Harmonic Bio, Inc.
CELCCelcuity Inc.
TNGXTango Therapeutics, Inc.
ELYMEliem Therapeutics, Inc.